A retired man in his sixties presented in 1995 with a history of tremor, gradually worsening over the preceding eight years. He described this as a postural and action tremor affecting his upper limbs symmetrically, but there were no parkinsonian symptoms. A maternal aunt had suffered with a tremor, but no other details were known, and alcohol did not affect his tremor. More recently he thought he had become unsteady on his feet, although this only troubled him when walking in the Himalayas! He was not on any medication and was otherwise well.
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On examination he was mildly dysarthric, had a postural tremor of the upper limbs with a superimposed action component, and his deep tendon reflexes were diminished. There was reduction to pain sensation in a stocking distribution. There were no other signs.
A diagnosis of either a neuropathy related tremor or essential tremor was considered, and the following tests were normal: neurophysiology, MR brain, cerebrospinal fluid, EEG, and routine blood tests, including the known SCA mutations, and immunoglobulins.
His tremor did not to respond to propranolol, isoniazid, or valproate and four years later both his tremor and unsteadiness had deteriorated. Reassessment revealed absent reflexes, his tremor remained postural and on action, with the frequency and amplitude of essential tremor. There was probably superimposed dysmetria and he had mild gait ataxia, but no other new signs. Repeat nerve conduction studies were again normal. A diagnosis of "atypical essential tremor" or "essential tremor plus" was suggested, and the tremor responded remarkably to primidone, allowing him to eat soup for the first time in a decade. Nonetheless, his unsteadiness and lower limb sensory disturbance worsened. A third visit to the neurophysiologist was again normal, and MR lumbar spine revealed degenerative disease, with probable nerve root impingement at the L4/5 level. He underwent surgical decompression with no improvement.
In 2003, six years after the original blood sample had been taken for SCA mutation analysis, the genetics laboratory reported that further analysis had revealed 74 repeat sequences in his Fragile Site Mental Retardation 1 gene (FMR1) (normally less than 55), confirming that he had a "premutation" of this gene, and suggesting a diagnosis of the then recently described fragile X tremor/ataxia syndrome (FXTAS). 1 2 tHe FRagile X tReMoR/ataXia SyNDRoMe Fragile X syndrome, the commonest inherited cause of mental retardation, is caused by an expansion of the CGG trinucleotide repeat sequences within the FMR1 gene, the full mutation having more than 200 repeats. Between 55 and 200 repeats is termed the premutation range, which is not usually associated with learning disability, although recent evidence has suggested some neuropsychological deficits. 3 Recently however, a new syndrome associated with this premutation has been described, initially in older men (>50 years), 1 and more recently in women too 4 (interestingly, premature ovarian failure is a recognised association in women with the premutation, affecting about 20%). These patients present with various neurological symptoms including progressive cerebellar ataxia, tremor, parkinsonism, dementia, peripheral neuropathy, and autonomic features. The commonest problems are a progressive ataxic syndrome and intention tremor, although in a small number of patients these features are less prominent. However, resting, postural, and action tremors have all been described in FXTAS and therefore a wide index of suspicion is required, and essential tremor is probably not a rare misdiagnosis in FXTAS.
Diagnostic criteria have been proposed (table) . These rely heavily on brain MR findings (fig 1) and our patient would only qualify as a "probable" according to this system (two major clinical symptoms, ataxia and intention tremor), although we have few doubts that the diagnosis is correct. It is possible that repeat MR scanning might by now show the typical features, but we have not performed this.
The pathophysiological mechanism by which premutation leads to disease is uncertain. In fragile X syndrome, associated with the full mutation, hypermethylation of the promoter region within the FMR1 gene leads to gene silencing. This is not thought to occur in FXTAS, and it has been suggested that raised FMR1 mRNA levels may lead to a toxic "gain of function" effect, similar to the mechanism proposed in myotonic dystrophy. 1 Clinical features of FXTAS do not occur in fragile X syndrome, consistent with this hypothesis.
The neuropathological findings in FXTAS have recently been described in detail, 5 typically significant white matter changes, enlarged inclusion-bearing astrocytes in the white matter, and intranuclear inclusions in neurons and astrocytes throughout the central nervous system, including autonomic neurons ( fig  2) . There is a strong association between the number of repeats and intranuclear inclusions, indicating that the number of CGG repeats is a predictor of disease severity.
It is important for neurologists, movement disorder specialists, and geriatricians to be aware of FXTAS. The prevalence of the premutation is estimated at 1 in 260 females and 1 in 800 males, so the syndrome may not be as rare as we might think (and thus perhaps appears incorrectly in the Neurological rarities section of this journal!). Incorrect initial diagnosis (as in our patient) is probably not uncommon, 6 and although a diagnosis will not presently lead to any specific treatment, it is important because genetic counselling of the family may be required, and a positive diagnosis will prevent further unnecessary investigations, or even treatment-in retrospect, the decision to operate on our patient was probably wrong, and we believe his sensory symptoms are part of FXTAS, despite the normal neurophysiology.
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Dr C Lueck (Canberra, Australia) initially cared for this patient, and most importantly had the foresight to request the genetic analysis several years before FXTAS was described.
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